Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:58:55 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



Q:PULM - PULMATRIX INCORPORATED - http://www.pulmatrix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PULM - Q0.61.91·2.210.11.90-0.1099-5.55.07422.01  2.0677  1.903.14  1.5516:00:01Mar 2815 min RT 2¢

Recent Trades - Last 10 of 42
Time ETExPriceChangeVolume
16:00:01Q2.03-0.016
15:59:39Q2.0399-0.00014
15:11:32Q1.955-0.08585
14:56:22Q1.9109-0.129113
14:56:22Q1.9109-0.129187
14:54:16Q1.9001-0.1099750
14:54:09Q1.915-0.12533
14:54:09Q1.92-0.125
14:54:09Q1.92-0.1211
14:53:38Q1.92-0.125

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-28 09:05U:PULMNews ReleasePulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update
2024-01-08 09:00U:PULMNews ReleasePulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives
2023-11-09 09:05U:PULMNews ReleasePulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update
2023-09-19 09:05U:PULMNews ReleasePulmatrix Announces FDA Acceptance of IND Application for PUR3100 to Treat Acute Migraine
2023-08-23 09:05U:PULMNews ReleasePulmatrix Announces Publication on Physiologically Based Pharmacokinetic Modelling of Potential Drug-Drug Interactions with PUR1900, Orally Inhaled Itraconazole
2023-08-10 09:05U:PULMNews ReleasePulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update
2023-07-11 09:05U:PULMNews ReleasePulmatrix Announces Submission of IND Application to FDA to Initiate a Phase 2 Trial of Investigational Drug PUR3100 to Treat Acute Migraine
2023-06-15 09:20U:PULMNews ReleasePulmatrix Presents PUR3100 Phase 1 Data at the 65th Annual Meeting of the American Headache Society
2023-05-24 09:05U:PULMNews ReleasePulmatrix Selected to Present at the Annual Biotechnology Innovation Organization (BIO) International Convention
2023-05-12 09:05U:PULMNews ReleasePulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update
2023-05-02 09:05U:PULMNews ReleasePulmatrix Supports World Asthma Day 2023